Al-Saidan S M, Krishnaiah Y S R, Chandrasekhar D V, Lalla J K, Rama B, Jayaram B, Bhaskar P
Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, Safat, Kuwait.
Skin Pharmacol Physiol. 2004 Nov-Dec;17(6):310-20. doi: 10.1159/000081117.
The objective of the present study was to formulate a hydroxypropyl methylcellulose (HPMC) gel drug reservoir system with ethanol-water as a solvent system and limonene as a penetration enhancer for enhancing the transdermal delivery of nicorandil so as to develop and fabricate a membrane-moderated transdermal therapeutic system (TTS). The in vitro permeation of nicorandil was determined across rat abdominal skin from a solvent system consisting of ethanol or various proportions of ethanol and water. The ethanol-water (70:30 v/v) solvent system that provided an optimal transdermal permeation was used in formulating an HPMC gel drug reservoir system with selected concentrations (0% w/w, 4% w/w, 6% w/w, 8% w/w or 10% w/w) of limonene as a penetration enhancer for further enhancement of transdermal permeation of nicorandil. The amount of nicorandil permeated in 24 h was found increased with an increase in the concentration of limonene in the drug reservoir system up to a concentration of 6% w/w, but beyond this concentration there was no further increase in the amount of drug permeated. The flux of nicorandil was 370.9 +/- 4.2 microg/cm2 x h from the drug reservoir system with 6% w/w of limonene, which is about 2.6 times the required flux to be obtained across rat abdominal skin for producing the desired plasma concentration for the predetermined period in humans. The results of a Fourier Transform Infrared study indicated that limonene enhanced the percutaneous permeation of nicorandil by partially extracting the stratum corneum lipids. It is concluded that the HPMC gel drug reservoir system prepared with a 70:30 v/v ethanol-water solvent system containing 6% w/w of limonene is useful in designing and fabricating a membrane-moderated TTS of nicorandil.
本研究的目的是制备一种以乙醇 - 水为溶剂体系、柠檬烯为渗透促进剂的羟丙基甲基纤维素(HPMC)凝胶药物储库系统,以增强尼可地尔的透皮给药,从而开发并制造一种膜控型透皮治疗系统(TTS)。通过由乙醇或不同比例乙醇和水组成的溶剂体系,测定尼可地尔在大鼠腹部皮肤的体外渗透情况。提供最佳透皮渗透的乙醇 - 水(70:30 v/v)溶剂体系用于制备含有选定浓度(0% w/w、4% w/w、6% w/w、8% w/w或10% w/w)柠檬烯作为渗透促进剂的HPMC凝胶药物储库系统,以进一步增强尼可地尔的透皮渗透。发现药物储库系统中尼可地尔在24小时内的渗透量随着柠檬烯浓度的增加而增加,直至浓度达到6% w/w,但超过该浓度后,药物渗透量不再增加。含有6% w/w柠檬烯的药物储库系统中尼可地尔的通量为370.9 +/- 4.2 μg/cm²·h,这约为在预定时间段内在人体中产生所需血浆浓度时,大鼠腹部皮肤所需通量的2.6倍。傅里叶变换红外研究结果表明,柠檬烯通过部分提取角质层脂质来增强尼可地尔的经皮渗透。结论是,用含有6% w/w柠檬烯的70:30 v/v乙醇 - 水溶剂体系制备的HPMC凝胶药物储库系统可用于设计和制造尼可地尔的膜控型TTS。